BFC Planning’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.3K Buy
205
+110
+116% +$2.53K ﹤0.01% 2846
2026
Q2
$2.11K Hold
95
– – ﹤0.01% 2980
2026
Q1
$1.72K Buy
+95
New +$1.64K ﹤0.01% 2630

Other funds holding DYN

BFC Planning's DYN Position: Q3 2026 in Review

BFC Planning increased its Dyne Therapeutics (DYN) stake by 116% in Q3 2026, buying an estimated $2.53K and bringing the position to 205 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

BFC Planning first reported a position in DYN in Q1 2026 and has held it in 3 quarters since. 179 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • BFC Planning held 205 shares of Dyne Therapeutics worth $3.3K as of Q3 2026.
  • BFC Planning bought 110 Dyne Therapeutics shares in Q3 2026, an estimated $2.53K.
  • Dyne Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2846 holding.
  • BFC Planning first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 179 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.